Additionally, the company has increased the proportion of Phase 3 programs with established proof-of-concept from 54% in 2022 to ... FDA Fast Track designation), litifilimab for systemic lupus ...

These designations are for the treatment of adult patients with certain severe autoimmune diseases, including systemic lupus erythematosus ... Proof-of-concept results are expected by the end ...

Boston Hematologist Dr. William Dameshek of the Tufts-New England Medical Center pioneered the concept of autoimmune ... Forbiddingly called systemic lupus erythematosus, or SLE (it has no simple ...

Background: Systemic lupus erythematosus ... as a potential strategy in systemic lupus erythematosus (SLE). With regard to intercellular communication, our CellChat analysis provided a comprehensive ...

In a new study, researchers evaluated the potential relationship between disordered eating attitudes and nutritional status ...

A new study explores the relationship between frailty, the proportion of health deficits present in an individual, as ...

Cutaneous lupus affects quality of life by limiting social participation and increasing mental health concerns, according to ...

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

New research shows caffeine supports blood vessel repair in lupus patients by boosting endothelial progenitor cell survival ...